Baptist Health Cancer Care | Strategic Alliance Partners
.png?fit=crop&auto=format)
About Baptist Health South Florida
Baptist Health South Florida is the largest healthcare organization in the region, with 12 hospitals, more than 27,000 employees, 4,000 physicians and 200 outpatient centers, urgent care facilities and physician practices spanning across Miami-Dade, Monroe, Broward and Palm Beach counties. Baptist Health has internationally renowned institutes specializing in cancer care, brain and spine care, heart and vascular care and orthopedic care. In addition, it includes Baptist Health Medical Group; Baptist Health Quality Network; and The Baptist Health PineApp, a virtual health platform. A not-for-profit organization supported by philanthropy and committed to its faith-based charitable mission of medical excellence, Baptist Health has been recognized by Fortune as one of the 100 Best Companies to Work For in America and is the most awarded healthcare system in South Florida by U.S. News and World Report. For more information, visit BaptistHealth.net/Newsroom and connect with us on Facebook, X (formerly Twitter), Instagram, TikTok and LinkedIn.
Connect with us:
Latest from Baptist Health Cancer Care
Dr Koehne on the Evolution of the Multiple Myeloma Treatment Paradigm
March 14, 2025
Video
Guenther Koehne, MD, discusses the roles of ASCT, CAR T-cell therapy, and bispecific antibodies in the treatment of patients with multiple myeloma.
Dr Somaiah on the Role of Chemotherapy in Sarcomas
February 26, 2025
Video
Neeta Somaiah, MD, discusses chemotherapy as the current mainstay of treatment in sarcoma subtypes and the emergence of immunotherapies in the space.
Experts Break Down Practice-Informing Presentations From the 2025 Genitourinary Cancers Symposium
February 19, 2025
Article
Experts across the field of GU oncology share important insights and spotlight key research presented at the 2025 GU Cancers Symposium.
Dr Ahluwalia on the Evolution of Precision Medicine in Oncology
February 13, 2025
Video
Manmeet Singh Ahluwalia, MD, MBA, FASCO, discusses oncology advances that were highlighted at the Miami Cancer Institute Precision Oncology Symposium.
Dr McCann on the Treatment Paradigm for HER2+ Breast Cancer With Brain Metastases
February 13, 2025
Video
Kelly E. McCann, MD, PhD, discusses current and evolving treatment strategies for patients with HER2-positive breast cancer who develop brain metastases.
Dr Ahluwalia on the SURVIVE Trial of SurVaxM Plus Chemoradiation in Newly-Diagnosed Glioblastoma
December 19, 2024
Video
Manmeet Singh Ahluwalia, MD, MBA, FASCO, discusses the phase 2b SURVIVE trial of SurVaxM plus chemoradiation in newly-diagnosed glioblastoma.
The Importance of Hematology/Medical Oncology Fellowship
October 22, 2024
Article
Samuel A. Kareff, MD, MPH, shares his reflections on the benefits, challenges, and critical elements of effective mentorship in hematology/oncology.
Phase 1 Trials Provide Oncology Fellows With Valuable Clinical Research Experience: With Samuel A. Kareff, MD, MPH
October 21, 2024
Podcast
Dr Kareff discusses the intersections between early-phase clinical research and meaningful mentorship experiences during oncology/hematology fellowship.
Tumor-Killing Technology in Head and Neck Cancer
August 19, 2024
Article
Noah Kalman, MD, MBA, details new technology for treating head and neck cancer, and ongoing trials examining therapies at Miami Cancer Institute.
Dr Garje on the Prognostic Value of HPV Status for Survival Outcomes in pSCC
June 10, 2024
Video
Rohan Garje, MD, discusses the impact of human papillomavirus status on survival outcomes in penile squamous cell carcinoma.
Dr Ahluwalia on the Incidence of Brain Metastases in RCC
June 10, 2024
Video
Manmeet Ahluwalia, MD, MBA, FASCO, discusses findings from a National Cancer Database analysis on treatment outcomes of brain metastases from primary RCC.
Advances With Erdafitinib Exemplify the Push For Precision Medicine in Urothelial Cancer
May 23, 2024
Article
Petros Grivas, MD, PhD, expands on key updates in the second-line management of urothelial cancer.
Dr Garje on Emerging Biomarkers in mCRPC
May 15, 2024
Video
Rohan Garje, MD, discusses emerging biomarkers in metastatic castration-resistant prostate cancer and where the treatment field is headed.
Dr Garje on the Utility of Lu 177 Vipivotide Tetraxetan in mCRPC
May 14, 2024
Video
Rohan Garje, MD, discusses the utility of lutetium Lu 177 vipivotide tetraxetan in metastatic castration-resistant prostate cancer.
Dr Koehne on the Use of Chemotherapy-Only Conditioning Regimens in Hematologic Malignancies
May 08, 2024
Video
Guenther Koehne, MD, PhD, discusses the use of chemotherapy-only conditioning regimens for patients with hematologic malignancies undergoing transplant.
Dr Garje on Selecting Between PARP Inhibitor Combinations in mCRPC
May 04, 2024
Video
Rohan Garje, MD, discusses considerations when choosing between FDA-approved PARP inhibitor–based combinations for patients with mCRPC.
Dr Diaz on the Evolution of Precision Medicine in Cervical Cancer
April 30, 2024
Video
John Paul Diaz, MD, discusses the evolving use of precision medicine approaches in cervical cancer management.
Garje Elucidates Biomarker-Driven Approaches Generating Excitement in Metastatic Prostate Cancer
April 26, 2024
Article
Rohan Garje, MD, highlights advances made in precision medicine approaches for the management of metastatic prostate cancer.
Dr Garje on the Use of Genomic Testing and Targeted Therapy in Prostate Cancer
April 23, 2024
Video
Rohan Garje, MD, discusses the evolving use of genomic testing and targeted treatment approaches in prostate cancer.
Breast Cancer Experts Share Obstacles and Successes as Women in Oncology
April 11, 2024
Podcast
Drs Graff, Mahtani, McCann, and Rugo share moments that sparked their interest in oncology and setbacks they overcame when building their careers.